Critical Care Nutrition Market Expected to Reach $19,237.81 Million by 2030

According to a new report published by Allied Market Research, titled, “Critical care nutrition market by Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2021–2030," the global critical care nutrition market was valued at $10,618.96 million in 2020, and is projected to reach $19,237.81 million by 2030, registering a CAGR of 6.3% from 2021 to 2030.

Critical care refers to the provision of nutrition intake that need to be provided especially to patients who are admitted to the ICU. The nutrition if provided in early phases helps in decreasing the severity, reducing the complications, and decreasing duration of stay in ICU. Furthermore, reduction in mortality rates is observed during early nutrition therapy. Critically ill patients in ICUs are susceptible to suffer from malnutrition. This deficiency of nutrients require early nutritional therapy for ICU patients. Nutritional support therapy includes enteral or parenteral provision of protein, electrolytes, calories, vitamins, minerals, trace elements, and fluids. Rise in number of patients who have been admitted to ICUs would propel the market growth in the next few years. In addition, increase in healthcare spending for targeted diseases such as cancer, gastrointestinal disorders, and neurological diseases fuels the market growth. Furthermore, the growth of the market is driven by advantages of early intake of nutritional therapy in critical care patients. Moreover, surge in demand to meet the nutrient deficiency in critically ill patients is expected to boost the revenue generation in the next few years.   

However, lack of awareness of critical care nutrition for patients admitted in the ICU in underdeveloped countries hinders the growth of critical care nutrition market. 

Conversely, development of new technologically advanced products and high growth potential in untapped emerging economies are expected to provide lucrative opportunities for the growth of the market. 

The global critical care nutrition market is categorized into route of administration, application, age group, and region. On the basis of route of administration, the market is categorized into enteral and parenteral. The applications covered in the report include cancer, neurological diseases, gastrointestinal disorders, and others. Depending on age group, the market is segregated into pediatric, adults, geriatric. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA

By route of administration, the enteral segment dominated the global critical care nutrition market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to the advantages associated with the enteral route of administration such as it enhances gastrointestinal tract’s (GI) blood flow and improves GI mucosal health. In addition, lesser side effects caused due to enteral route of administration will help the segment gain traction during the forecast period. 

By application, the cancer segment registered the fastest growth in 2020, and is anticipated to continue this trend in the commenced period. This is attributed to the adoption of sedentary lifestyle leading to increase in incidence of cancer, which, in turn, is expected to propel the demand for critical care nutrition.

On the basis of patient group, the geriatric segment registered the highest CAGR, owing to higher number of patients suffering from chronic diseases such as diabetes, cancer, and gastrointestinal disorders. Thus, geriatric population requires critical care nutrition, which is expected to contribute to the critical care nutrition market growth.

North America is expected to remain dominant during the forecast period, owing to surge in demand for critical care nutrition, increase in incidence of cancer, and presence of major key players along with R&D centers. However, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to surge in utilization of critical care nutrition for quicker healing & management of diseases and increase in improvement in healthcare infrastructure in the coming years. 

Key Findings Of The Study 

• Depending on route of administration, the enteral segment held largest share in the global critical care nutrition market in 2020.
• On the basis of patient group, the pediatric segment garnered the largest share in 2020, and is expected to remain dominant throughout the forecast period. 
• By application, the neurological diseases acquired the highest market share in the global critical care nutrition market in 2020, and is anticipated to gain traction in the coming years.
• Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.4% during the forecast period.